title: Prostaglandin E2 potentiation of P2X3 receptor mediated currents in dorsal root ganglion neurons.
abstract: Prostaglandin E2 (PGE2) is a well-known inflammatory mediator that enhances the excitability of DRG neurons. Homomeric P2X3 and heteromeric P2X2/3 receptors are abundantly expressed in dorsal root ganglia (DRG) neurons and participate in the transmission of nociceptive signals. The interaction between PGE2 and P2X3 receptors has not been well delineated. We studied the actions of PGE2 on ATP-activated currents in dissociated DRG neurons under voltage-clamp conditions. PGE2 had no effects on P2X2/3 receptor-mediated responses, but significantly potentiated fast-inactivating ATP currents mediated by homomeric P2X3 receptors. PGE2 exerted its action by activating EP3 receptors. To study the mechanism underlying the action of PGE2, we found that the adenylyl cyclase activator, forskolin and the membrane-permeable cAMP analogue, 8-Br-cAMP increased ATP currents, mimicking the effect of PGE2. In addition, forskolin occluded the enhancement produced by PGE2. The protein kinase A (PKA) inhibitors, H89 and PKA-I blocked the PGE2 effect. In contrast, the PKC inhibitor, bisindolymaleimide (Bis) did not change the potentiating action of PGE2. We further showed that PGE2 enhanced alpha,beta-meATP-induced allodynia and hyperalgesia and the enhancement was blocked by H89. These observations suggest that PGE2 binds to EP3 receptors, resulting in the activation of cAMP/PKA signaling pathway and leading to an enhancement of P2X3 homomeric receptor-mediated ATP responses in DRG neurons.
authors: Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555-1069, USA. conwang@utmb.edu
authors: Congying
authors: C
authors: Wang
authors: Guang-Wen
authors: GW
authors: Li
authors: Li-Yen Mae
authors: LY
authors: Huang
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D015232:Dinoprostone / Q000494:pharmacology*; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018408:Patch-Clamp Techniques; D058910:Purinergic P2 Receptor Agonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D058477:Receptors, Purinergic P2X3
chemical_list: D058910:Purinergic P2 Receptor Agonists; D058477:Receptors, Purinergic P2X3; D000255:Adenosine Triphosphate; D015232:Dinoprostone
references: Physiol Rev. 2002 Oct;82(4):1013-67
references: 12270951
references: Br J Pharmacol. 1999 May;127(2):449-56
references: 10385245
references: J Biol Chem. 2003 Sep 26;278(39):37344-51
references: 12869560
references: Br J Pharmacol. 2003 Dec;140(8):1381-8
references: 14623769
references: Nat Neurosci. 2002 Jan;5(1):34-40
references: 11740501
references: J Neurosci. 2002 Jan 1;22(1):93-102
references: 11756492
references: J Neurophysiol. 1999 Sep;82(3):1590-8
references: 10482772
references: Physiol Rev. 1999 Oct;79(4):1193-226
references: 10508233
references: J Comp Neurol. 2005 Jan 24;481(4):377-90
references: 15593340
references: J Biol Chem. 2004 Dec 31;279(53):55176-86
references: 15498767
references: J Physiol. 2005 Apr 15;564(Pt 2):437-50
references: 15705651
references: Pain. 2005 Dec 15;119(1-3):38-48
references: 16298067
references: Curr Pharm Des. 2006;12(8):971-5
references: 16533164
references: Pharmacol Ther. 2006 Jun;110(3):433-54
references: 16226312
references: Pflugers Arch. 2006 Aug;452(5):598-607
references: 16547751
references: Br J Pharmacol. 2006 Jul;148(6):845-52
references: 16770326
references: JAMA. 2006 Oct 4;296(13):1653-6
references: 16968830
references: J Biol Chem. 2000 Apr 7;275(14):10190-5
references: 10744703
references: Br J Anaesth. 2000 Apr;84(4):476-88
references: 10823099
references: J Neurosci. 2000 Jun 15;20(12):4680-5
references: 10844037
references: J Auton Nerv Syst. 2000 Jul 3;81(1-3):146-51
references: 10869713
references: Brain. 2000 Jun;123 ( Pt 6):1238-46
references: 10825361
references: Nature. 2000 Oct 26;407(6807):1011-5
references: 11069181
references: Nature. 2000 Oct 26;407(6807):1015-7
references: 11069182
references: Br J Pharmacol. 2001 Jan;132(1):259-69
references: 11156585
references: Annu Rev Pharmacol Toxicol. 2001;41:661-90
references: 11264472
references: J Biol Chem. 2001 May 11;276(19):16083-91
references: 11278900
references: J Physiol. 2001 Jul 15;534(Pt. 2):437-45
references: 11454962
references: J Neurosci. 2001 Sep 1;21(17):6522-31
references: 11517241
references: Biochem Biophys Res Commun. 2002 Mar 1;291(3):611-6
references: 11855833
references: J Neurosci. 2000 Aug 1;20(15):RC90
references: 10899177
references: Pain. 2002 Apr;96(3):285-96
references: 11973001
references: Am J Physiol Regul Integr Comp Physiol. 2002 Jun;282(6):R1618-27
references: 12010743
references: J Neurosci. 2002 Sep 1;22(17):7444-52
references: 12196566
references: J Neurophysiol. 2002 Sep;88(3):1512-22
references: 12205171
references: Pain. 2002 Sep;99(1-2):11-9
references: 12237180
references: Nat Rev Neurosci. 2004 Feb;5(2):135-45
references: 14735116
references: J Neurosci. 2004 Jan 21;24(3):642-51
references: 14736850
references: J Physiol. 2004 Jan 15;554(Pt 2):301-8
references: 12832496
references: Nucleic Acids Res. 2004;32(5):e49
references: 15026538
references: Science. 2004 May 7;304(5672):884-7
references: 15131310
references: Biochem J. 2004 Aug 15;382(Pt 1):101-10
references: 15144237
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11868-73
references: 15292517
references: J Biol Chem. 2004 Sep 17;279(38):39485-94
references: 15262999
references: Eur J Pharmacol. 1981 Dec 17;76(4):391-401
references: 6173240
references: Pain. 1988 Jan;32(1):77-88
references: 3340425
references: J Neurosci Methods. 1994 Jul;53(1):55-63
references: 7990513
references: J Neurosci. 1995 May;15(5 Pt 1):3357-65
references: 7751915
references: Br J Pharmacol. 1995 Dec;116(7):2828-37
references: 8680713
references: FEBS Lett. 1996 May 20;386(2-3):165-8
references: 8647273
references: Nature. 1997 May 29;387(6632):505-8
references: 9168113
references: Nature. 1997 Oct 16;389(6652):749-53
references: 9338789
references: Neuropharmacology. 1997 Sep;36(9):1229-42
references: 9364478
references: Eur J Pharmacol. 1997 Dec 11;340(2-3):227-41
references: 9537820
references: J Neurochem. 1998 Jun;70(6):2606-12
references: 9603227
references: J Neurosci. 1998 Aug 15;18(16):6081-92
references: 9698303
references: J Neurosci. 1998 Nov 15;18(22):9238-44
references: 9801363
references: Eur J Neurosci. 1998 Nov;10(11):3470-8
references: 9824460
references: J Neurosci. 1998 Dec 15;18(24):10345-55
references: 9852572
references: J Neurophysiol. 1998 Dec;80(6):3356-60
references: 9862932
references: Br J Pharmacol. 1999 Jan;126(1):326-32
references: 10051152
references: Eur J Neurosci. 1999 Mar;11(3):946-58
references: 10103088
references: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84
references: 12482951